Incubation of peripheral lymphocytes (PBL) from normal donors with pokeweek mitogen (PWM) induced terminal differentiation by B lymphocytes to immunoglobulin (Ig) synthesizing and secreting plasma cells. B cells from hypogammaglobulinemic patients with different primary immunodeficiencies failed to undergo functional differentiation after similar treatment with PWM. Co-cultures of BL from normal donors and hypogammaglobulinemic patients often resulted in deviations, both positive and negative, from expected levels of PWM-stimulated intracellular Ig biosynthesis. Suppression of B-cell differentiation was manifested by PBL from patients with several different primary immunodeficiencies, including infantile sex-linked agammaglobulinemia. Immunoregulatory activities were noted to vary with the normal donor used in co-culture experiments and with time. Cell populations that were active in influencing B-cell differentiation to functional plasma cells did not have an appreciable modulatory effect on T-lymphocyte responses to mitogens. These observations may provide a functional subclassifications for immunoregulatory cells in man.
A B S T R A C T Incubation of peripheral lymphocytes (PBL) from normal donors with pokeweed mitogen (PWM) induced terminal differentiation by B lymphocytes to immunoglobulin (Ig) synthesizing and secreting plasma cells. B cells from hypogammaglobulinemic patients with different primary immunodeficiencies failed to undergo functional differentiation after similar treatment with PWM. Co-cultures of PBL from normal donors and hypogammaglobulinemic patients often resulted in deviations, both positive and negative, from expected levels of PWM-stimulated intracellular Ig biosynthesis. Suppression of B-cell differentiation was manifested by PBL from patients with several different primary immunodeficiencies, including infantile sex-linked agammaglobulinemia. Immunoregulatory activities were noted to vary with the normal donor used in co-culture experiments and with time. Cell populations that were active in influencing B-cell differentiation to functional plasma cells did not have an appreciable modulatory effect on T-lymphocyte responses to mitogens. These observations may provide a functional subclassification for immunoregulatory cells in man.
INTRODUCTION
Modulation of the normal immune response requires a delicate balance between immunologic-enhancing activities and inhibitory effects. With regard to the latter, cells that can suppress humoral or cellmediated immune functions have been extensively described in a number of animal models (for review, see reference 1). The recent association of suppressor cells in several human disease states Receivedfor publication 20 September 1976 and in revised form 16 February 1977. involving immune dysfunction (2) (3) (4) (5) suggests a role for these cells in the pathogenesis of immunodeficiency in man.
Waldmann and his colleagues (2) showed that T lymphocytes isolated from patients with hypogammaglobulinemia inhibit immunoglobulin (Ig)l production by pokeweed mitogen (PWM)-stimulated normal lymphocytes in co-cultures. It was proposed that these suppressor cells subserve a pathogenetic basis for the hypogammaglobulinemia of common variable immunodeficiency (CVI). Other investigations, however, demonstrated that suppressor activity in both benign and neoplastic diseases may also be manifested by inhibition of T-lymphocyte functions, namely, allogeneic stimulation (3) and blastogenic responses to mitogens and antigens (5) . The latter noted that no suppression of Ig production occurred when patient lymphocytes known to inhibit proliferative responses were co-cultured with normal cells.
In this paper, we demonstrate that the molecular basis of the Ig suppressor effect after PWM induction is the inhibition of Ig biosynthesis as contrasted to a block in transmembrane secretion of intracellular Ig and that suppressor cell populations in several immunodeficiency diseases characterized by hypogammaglobulinemia are selectively active on B cellderived functions of normal lymphocytes. We further studied the role of suppressor as well as enhancing activity in both cell-mediated and humoral immunity in different immunodeficiency diseases.
METHODS
Patients and normal donors. Diagnosis and classification of immunodeficiency states were made using the guidelines of the World Health Organization Expert Committee (6, 7) . A profile of clinical and immunologic parameters for the patients under investigation is presented in Table I . All patients for these studies were under the care of physicians of the Immunobiology Clinic of the Memorial Sloan-Kettering Cancer Center, and informed consent was obtained in accordance with Department of Health, Education, and Welfare and institutional policies as approved by our Clinical Investigation Committee. Specimens from pediatric patients were obtained with the authorization and supervision of the responsible pediatrician.
Isolation of lymphocytes. Peripheral blood lymphocytes (PBL) were prepared from fresh heparinized blood (20 U heparin/ml) by a modification of the density gradient technique of Boyum (8) . The mononuclear cell band was harvested and washed three times with Ca++-and Mg++-free Hanks' balanced salt solution (Grand Island Biological Co., Grand Island, N. Y.) and resuspended in RPMI 1640 medium (Grand Island Biological Co.) containing 20% heat-inactivated fetal calf serum (Associated Biomedic Systems, Inc., Buffalo, N. Y.), 8 .0 ,ug gentamicin (Schering Corp., Kenilworth, N. J.), and 300 ,ug of glutamine/ml.
Cell culture and preparation of lysates. All cultures consisted of a total of 5 x 106 lymphocytes in 5 ml RPMI containing 50 ,ug of PWM (Grand Island Biological Co.) in a polypropylene tube (Falcon Plastics, Oxnard, Calif.). Autologous control cultures contained 5 x 106 total cells and the co-cultures were performed by adding 2.5 x 106 lymphocytes from patients with hypogammaglobulinemia to an equal number of lymphocytes from healthy, volunteer donors. The cells were cultured for 7 days in a humidified After sedimenting the cells from the supernate, they were lysed with 2 ml of 1% solution of Nonidet P-40 (Particle Data, Inc., Elmhurst, Ill.) in 0.05 M Tris HCI (pH 7.6), 0.025 M KC1, and 0.005 M MgCl2 (TKM), and subcellular particles were pelleted by centrifugation at 105,000 g for 60 min as previously described (9) . Any radiolabeled Ig in the culture supernate is actively secreted, whereas the cell lysate contains only de novo synthesized labeled Ig. Both the culture supernate and the cell lysate were dialyzed against 0.01 M phosphate buffered saline, pH 7.5 (PBS), and TKM, respectively, to remove any free [3H]leucine. Preparation of antisera and serologic assay for Ig. Methodolologic details have been recently described (10) , thus only major points will be summarized. New Zealand white rabbits were immunized by two separate intramuscular injections consisting either of 2.5 mg keyhole limpet hemocyanin (KLH; Schwartz/Mann, Orangeburg, N. Y.) or 0.5 mg human F(ab')2 in 0.5 ml of PBS emulsified with 1.5 ml of complete Freund's adjuvant (Difco Laboratories, Detroit, Mich.). This was followed by similar inoculations 6 wk after the first. 2 wk after the secondary immunization, the animals were bled and the sera heatinactivated. All the sera were monospecific, and no crossreactivity between the antigens under study was observed. To remove any materials which might nonspecifically interact with the rabbit antiserum-antigen matrix, a volume of neat rabbit anti-KLH serum capable of precipitating 50 ,&g of antigen was added to each 2-ml sample, followed by 50 ,tg of unlabeled KLH. The mixture was incubated at 37°C for 60 min and overnight at 4°C. The resulting precipitate was discarded, and the supemate was divided into two equal aliquots. One aliquot was incubated with 1178 S. Schwartz (1 _Ig cpml5 x 10" cells in co-culture x 100 k (0.5 x Ig cpm/5 x 106 donor cells ) + 0.5 x Ig cpm/5 x 106 patient cells). Note that when the observed count was higher than the predicted value, the enhancement above 100o is indicated by a "+" sign before the result.
Mitogen stimulation experiments. Isolation of cells and culture conditions have been previously described (11) . Briefly, PBL from patients at a concentration of approximately 2-4 x 106 cells/ml were pretreated with mitomycin C (MC; Sigma Chemical Co., St. Louis, Mo.) diluted to 50 Ag/ml for 30 min. A 0.1-ml aliquot containing 5 x 106 freshly prepared untreated responder lymphocytes from healthy donors was mixed with an equal volume and number of MC-pretreated allogeneic patient cells in microculture plates. Control cultures consisted of5 x 104 untreated responder lymphocytes plus an equal number of MCtreated allogeneic cells from another normal donor. Various concentrations of either one of the mitogens, phytohemagglutinin-P (PHA, 2.5 pLg/ml), concanavalin A (Con A, 60,ig/ml), or PWM (20 Ag/ml) were added to designated cultures, and the cells were incubated for 5 days in a humidified 5% C02, 95% air incubator at 37°C. Extensive studies have shown that these final concentrations of mitogens are within the optimal range for stimulation of lymphocyte transformation (12) . During the last 16 h of incubation, 2 ACi of [3H]thymidine was added to each well. The cells were collected by an automatic harvester and incorporation of [3H]thymidine into DNA was measured by using a liquid scintillation counter. Percentage of mitogenic stimulation of responder cells influenced by the addition of patient's lymphocytes to co-cultures was calculated according to the following formula which acknowledges the contribution of allogeneic stimulation in the absence of mitogens: 
RESULTS
Specificity of the radioimmunoassay for Ig synthesis and secretion. A direct serologic precipitation assay for radiolabeled Ig, which was noted to trap considerably less nonspecific radiolabel than a previously employed indirect double antibody technique, was used in these studies. Table II presents representative data concerning synthesis and secretion of Ig by PBL from a normal individual, anagammaglobulinemic patient, and the co-culture of the two. The table shows that the PBL of the normal person synthesize and secrete Ig in relatively large amounts after stimulation with PWM, whereas the agammaglobulinemic cells show minimal synthesis and secretion of Ig. When cultured together, the normal and agammaglobulinemic lymphocytes synthesize and secrete amounts of Ig considerably less than would be predicted by the mean of these activities of the two individual cell populations. Note that the counts in the nonspecific serologic controls for the normal donor lymphocytes are less than 5% of the specific counts for both the proteinrich intracellular lysate and the culture supemate whose major human protein component is secreted Ig. By contrast, the total counts recovered in the serologic assays for the hypogammaglobulinemic patients were merely equivalent to background, reflecting little to no synthesis of Ig. The failure of our specific antisera to react with the products of the agammaglobulinemic lymphocyte cultures is a good biologic control for its specificity.
Pokeweed mitogen stimulation of Ig synthesis and secretion by cultured human lymphocytes. As shown in Fig. 1 treatment of lymphocytes from hypogammaglobulinemic patients, however, fails to stimulate significant amounts of Ig synthesis or secretion (Fig. 1 B) . With regard to these latter studies involving patients with a variety of primary immunodeficiencies manifested by hypogammaglobulinemia among other diagnostic criteria, mean values of 262±88 and 1,082+456 cpm for intracellular and secreted Ig, respectively, were obtained. Thus the extremely low serum Ig levels in these patients were also paralleled by a decreased in vitro Ig synthetic capacity of the lymphocytes cultured in the presence of PWM. Effect of co-culture of normal lymphocytes on Ig synthesis and secretion. Because we co-cultured allogeneic cells, patient and normal, it was necessary to determine whether or not allogeneic stimulation affected PWM induction of Ig. To exclude the possibility of allogeneic effect, equal numbers of cells were incubated either alone or in co-culture. The data in Fig. 2 demonstrate that the admixture of equal numbers of cells from healthy volunteer donors does not appreciably affect the amount of Ig synthesized or secreted as predicted from the amounts recovered from individual autologous cultures. Thus, profound suppressor or enhancing activity is not readily manifested by the normal, healthy population at large. We have occasionally 1180 S. Schwartz, Y. Choi, L. Shou, and R. Good found significant deviations from the expected values in co-culture experiments with purportedly normal donors; however, a subsequent detailed clinical history has then regularly revealed underlying medical problems in one member of the pair. Although no attempt was made to HLA type these normal donors, their random selection precludes significant matching, eliminating the role of allogeneic stimulation on Ig synthesis in mixing experiments. Furthermore, sex differences did not seem to affect the co-cultures.
Effect of co-cultures of lymphocytes from hypogammaglobulinemic patients and normal donors on Ig synthesis and secretion. Co-cultures of lymphocytes between normal donors and hypogammaglobulinemic patients with several different primary immunodeficiencies often resulted in significant deviations from the expected values of Ig synthesis and secretion based upon activities in the respective autologous cultures. Most notable was suppression of Ig synthesis and secretion as presented in Tables III-V. In all cases where suppression of Ig secretion was noted, this merely paralleled inhibition of intracellular biosynthesis. No separation between these two functions was observed, that is, suppression of secretion of Ig in the presence of continued intracellular synthesis. A concomitant analysis of viability using trypan blue dye exclusion did not reveal any differences between control and experimental cultures, decreasing the likelihood that cytotoxicity caused the suppression. In contrast to the above suppressor activity, other cocultures resulted in a striking enhancement of Ig synthesis and secretion (Table VI) . As presented, percent enhancement refers to the percent increase above the predicted value equivalent to 100%. Significant suppression of enhancement was only seen in lymphocyte co-cultures containing cells from patients with primary immunodeficiencies and was not observed in "normal" allogeneic mixtures except as noted above. As with the suppressor effect, enhancement occurred proportionately in both the intracellular and extracellular fractions. Enhancement or suppression of Ig synthesis was not limited to cells from patients with any particular immunodeficiency diagnosis as is evident from Tables III-VI. Finally, several hypogammaglobulinemic patients with different primary immune deficiency states including CVI did not show any enhancement or suppression of PWMstimulated Ig synthesis (data not shown).
Variability of modulation effect with different normal donors. Because many patients involved in this study were lymphopenic and/or anemic, we were often unable to obtain sufficient numbers of cells for extensive analyses. Hence, the frequent use of only one normal donor in co-cultures was limited by the availability of patients' cells. On occasion we were able I 8 . 0 CL S S1 a.4 lntracellular lg to obtain enough patient cells for admixture with either of two different normal donors. The data in Table VII show that the expression of either enhancing or suppressor activity may vary, depending upon the normal donor used. Experiment I involves the use of two different normal donors with lymphocytes from a single patient, W. St., a 44-year-old man with a benign thymoma and associated hypogammaglobulinemia. When the patient's cells were co-cultured with lymphocytes from normal R, profound suppression of Ig synthesis and secretion occurred; however, admixture with cells from normal A failed to demonstrate any suppression. On another occasion lymphocytes from W. St., however, were suppressive for Ig synthesis and secretion for a different normal donor as well as normal A (Table V) . It should be further noted that in additional experiments involving cells from other normal donors, as compared to lymphocytes from normal A, suppression of the latter by cells of immunodeficient patients was consistently less in simultaneous experiments than the other normals studied.
The paired experiments 2 and 3, as well as 4 and 5, in Table VII reflect the use of different normal lymphocytes in co-culture with the patient's cells on separate occasions. Here the difference is even of greater magnitude with suppression occurring at one time and enhancement at another.
Effect of co-culture of lymphocytes on mitogenic responses. To determine if cell populations from hypogammaglobulinemic patients with diverse primary immunodeficiencies were capable of inhibiting proliferative responses, cultures consisting of normal responder lymphocytes stimulated with added mitogens plus MC-treated mononuclear cells from patients were established. These results are presented in Fig. 3 . No statistically significant difference in proliferative responses could be noted whether allogeneic MGtreated cells were obtained from healthy donors or hypogammaglobulinemic patients with primary immunodeficiencies. Furthermore, significant deviations from the range of normal values were not frequently seen in the experimental cultures containing patients' PBL. However, the most heterogeneous re-Regulation of Immunoglobulin Synthesis 1181 sponses, including a number of co-cultures which resulted in less than the predicted amount of [3H]thymidine incorporation, were observed when the cultures had been stimulated with PWM, a lectin known to activate both T and B lymphocytes. A comparison of PBL from individual patients known to either suppress or enhance Ig synthesis and secretion failed to reveal any correlation with stimulatory or suppressive influences on proliferative responses to the lectins.
DISCUSSION
Ig deficiency syndromes may have a genetic basis, for example infantile sex-linked agammaglobulinemia, Bruton's disease (13) . Some may be acquired as an idiopathic disorder or may be a secondary manifestation of other diseases, such as neoplasia or viral infection. These hypogammaglobulinemias can be further classified on the basis of the presence, as in CVI, of surface membrane Ig-bearing B lymphocytes tive, of both individuals. That the potential for suppressor activity may exist in the normal, healthy population has recently been reported by Shou and co-workers (11) . Thus, any individual's modulator capacity may vary as a consequence of the day-to-day immunologic changes associated with diet, environmental factors, infections, etc. Variation of suppressor activity as a function of the normal donor used was also recently reported by Broom et al. (30) . It is interesting to note that in our studies, cells from one specific donor, normal A, were consistently less suppressed than those of other volunteers when cocultured with cells from a number of hypogammaglobulinemic individuals and coincidentally, PWMstimulated Ig synthesis and secretion by normal A was always most vigorous. This individual may be an example of someone whose balance between helper and suppressor cell activity may be weighted in favor of the former. Support for such a model also comes from our observations that a single normal donor can vary at different times with regard to PWM-stimulated Ig synthesis response in vitro. Further analysis of the mechanisms involved in these apparently complex relations may derive from correlative studies of the TM, and T, subpopulations of lymphocytes recently described by Moretta et al. and others (31, 32) . A subclassification of immunoregulatory cell populations in man may be made on the basis of differential modulations of B or T cell-associated activities as our data suggest. Thus, patients with clinically defined humoral immune deficiencies can manifest in vitro perturbations of B-cell differentiation and function without a concomitant effect on such T-lymphocyte properties as mitogen-stimulated DNA synthesis. We are currently investigating whether the reciprocal situation also exists, that is, whether patients with isolated cell-mediated immune defects can manifest selective in vitro regulation of mitogen responses in the absence of effects on Ig metabolism.
